{
    "nct_id": "NCT04316975",
    "official_title": "Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus",
    "inclusion_criteria": "* No prior history of endoscopic treatment therapy for BE\n* Previously untreated \"treatment na√Øve\" disease history with confirmed histopathology analysis of at least one of the following:\n\n  * Low- or high-grade dysplastic BE (history of endoscopic mucosal resection (EMR)) is allowable or\n  * Intramucosal adenocarcinoma (IMC)\n* BE lesion length of at least: C0, M1\n* At least 18 years of age at time of consent\n* Able and willing to provide written informed consent\n* Able and willing to comply with required study procedures and follow-up schedule\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of endoscopic intervention for the treatment of gastroesophageal reflux disease (GERD), BE, or IMC (prior EMR is allowable)\n* Current esophageal stenosis/stricture preventing advancement of a therapeutic scope or significant esophageal anatomic abnormalities (masses, obstructive lesions, etc.)\n* Dysplasia of intestinal metaplasia (IM) confined only to the gastric cardia (BE Prague Criteria: C0M0)\n* Uncontrolled coagulopathy\n* Severe medical comorbidities precluding endoscopy, or limiting life expectancy to less than 2 years in the judgment of the endoscopist\n* Known portal hypertension, visible esophageal varices, or history of esophageal varices\n* Previous esophagectomy surgery involving the gastroesophageal junction (history of a fundoplication is OK)\n* General poor health, multiple co-morbidities placing the patient at risk, or otherwise unsuitable for trial participation\n* Subject has any condition that, in the opinion of the investigator or sponsor, would interfere with accurate interpretation of the study endpoints or preclude participation in the trial",
    "miscellaneous_criteria": ""
}